Teva Pharmaceuticals, an Israel-based drug manufacturer, has agreed to settle more than 3,000 opioid cases up to $4.25 billion in all cash over the next 13 years, according to The New York Times and Bloomberg.
Read the full post on Becker's Hospital Review - Healthcare News
